GlassScriptPhysician profile
Tara Janae Breaux
NPI 1831366087
$1,523.13
in general payments reported to CMS, 2019-2025
20 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $358 · 2023: $357 · 2024: $122 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.36 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $203.71 | 2021-2024 | Veozah |
| Mayne Pharma Commercial LLC | $197.25 | 2021-2025 | |
| Abbvie INC. | $176.42 | 2021-2023 | |
| Exeltis, USA INC. | $148.46 | 2021-2025 | Slynd, Tyblume |
| Takeda Pharmaceuticals U.S.A., INC. | $138.45 | 2021-2022 | |
| Daiichi Sankyo INC. | $134.74 | 2021-2022 | |
| Amgen INC. | $93.22 | 2022-2025 | Evenity, Prolia, Prolia |
| Becton, Dickinson and Company | $68.00 | 2021 | |
| Lilly USA, LLC | $62.89 | 2022-2023 | Mounjaro |
| Millicent US INC | $58.74 | 2025 | Femlyv, Intrarosa |
| Novo Nordisk INC | $39.68 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.90 | 2022 | |
| Exact Sciences Corporation | $32.99 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $28.80 | 2024 | |
| Axonics, INC. | $23.54 | 2024 | Axonics |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $19.48 | 2024 | Ova1 |
| Boston Scientific Corporation | $19.48 | 2025 | Axonics |
| Agile Therapeutics, INC. | $15.68 | 2022 | |
| Avion Pharmaceuticals | $15.40 | 2022 | |
| Therapeuticsmd, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Breaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.